vindesine has been researched along with Uterine Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boes, GH; Colombo, N; De Oliveira, CF; Lacave, AJ; Teodorovic, I; van der Burg, ME; Vermorken, JB; Zanetta, G | 1 |
1 trial(s) available for vindesine and Uterine Neoplasms
Article | Year |
---|---|
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Europe; Female; Humans; Middle Aged; Mitomycin; Prospective Studies; Survival Analysis; Treatment Outcome; Uterine Neoplasms; Vindesine | 2001 |